2561 — Visen Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- HK$5.31bn
- HK$5.09bn
Annual cashflow statement for Visen Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -289 | -250 | -182 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 88.7 | 46.6 | 26.2 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -53.6 | -75.3 | 10.8 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -247 | -271 | -141 |
| Capital Expenditures | -1.77 | -0.52 | -0.117 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -1.77 | -0.52 | -0.117 |
| Financing Cash Flow Items | -2.17 | -2.01 | 0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -7.95 | -6.95 | -3.09 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -256 | -279 | -144 |